-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$4.33308.49% Upside
Cue Biopharma, Inc. Frequently Asked Questions
-
What analysts cover Cue Biopharma, Inc.?
Cue Biopharma, Inc. has been rated by research analysts at Jefferies, JMP Securities, Piper Sandler in the past 90 days.